All animal experiments were approved by local state authorities (Regierung von 3 Unterfranken), comply with the ARRIVE guidelines and are carried out in accordance 4 with the EU Directive 2010/63/EU for animal experiments as well as the German 5
gene expression arrays (TaqMan ® Universal PCR Master Mix, ThermoFisher 1 Scientific, The Netherlands) specific for mouse: Nox4 (Mm00479246_m1, 2
ThermoFisher Scientific, The Netherlands), mouse Cyclophilin (Mm02342430_g1, 3
ThermoFisher Scientific, The Netherlands), Gapdh (Mm99999915_g1, ThermoFisher 4 Scientific, The Netherlands) and human: Nox4 (Hs00418353_m1, ThermoFisher 5 Scientific, The Netherlands), Gapdh (Hs02758991_g1, ThermoFisher Scientific, The 6 Netherlands). Water controls were included to ensure specificity and the comparative 7
ΔΔCt method was used for relative quantification of gene expression. 8
Cell specific Nox4 KO mice generation 9
Constitutive Nox4 KO mice and floxed Nox4 mice were generated as described (1) . 10
To generate endothelial-specific Nox4 KO (eNox4 KO) mice, female mice 11 (homozygous for the floxed NOX4 gene) were bred with male mice (C57Bl6 strain 12 background) that express the Cre recombinase gene under control of the endothelial-13 cell specific Tie2 promotor (2). As the Cre is located on the X chromosome, all males 14 used for this breeding were hemizygous for the Cre gene (Cre +/y ). During breeding, 15 only males that bear the Cre gene were selected for future breeding rounds, while 16 females were not allowed to bear the Cre. For experiments Cre positive (eNox4 KO) 17 males were used. Smooth muscle cell-specific and neuron specific Nox4 KO mice 18 were generated in an analogous way using SMMHC-CreERT2 mice (2) and CamKII 19
Cre (3) (EMMA ID number 01153) mice respectively. Deletion of NOX4 in SMC and 20 neurons was induced using Tamoxifen as described (4). For tMCAO, male 8-10 weeks 21
old Cre positive mice treated with tamoxifen (sNox4 KO and nNox4 KO) were used. 22
For all three lines Cre negative NOX4FF mice were used as controls (WT), with the 23 WT groups for the SMC and neuron specific lines also being injected with tamoxifen. 24
25
Verification of NOX4 deficiency in eKO, nKO and sKO mice 1 Histology and immunohistochemistry were performed according to standard 2 procedures (5). The cell-specific Nox4 KO mice validation was performed on formalin 3 fixed paraffin embedded tissue (brain or aorta) that was pre-treated with Proteinase K 4 prior to antibody incubation. For specific staining, the following antibodies were used: 5 pAb anti -CD31 (Biorad, MCA2388), NOX4 (kindly provided by A.M. Shah, King's 6
College London British Heart Foundation Centre, London) and anti-NeuN (Millipore, 7 MAB337). DNA was visualized with Hoechst and sections were coverslipped using 8 Aqua Poly Mount. All sections were analyzed with a Nikon Eclipse 50 microscope 9 equipped with the DS-U3 DS camera control unit and NIS-Elements software (Nikon, 10
Tokyo, Japan). 11
NOX4 expression in bone marrow flushes 12
Bone marrow samples from endothelial NOX4 KO and their respective WT mice were 13 collected. mRNA isolation and cDNA preparation were prepared as previously 14 described. mRNA levels of Nox4 were quantified by using the fluorescent Taqman ® 15 technology. ß-actin were used as reference gene. We used TaqMan ® gene expression 16 arrays (TaqMan ® Universal PCR Master Mix, ThermoFisher Scientific, The 17 Netherlands) specific for mouse: Nox4 (Mm00479246_m1, ThermoFisher Scientific, 18
The Netherlands), Nox2 (Mm1287743_m1, ThermoFisher Scientific, The 19 Netherlands) and ß-actin (Mm02619580_g1, ThermoFisher Scientific, The 20 Netherlands). Water controls were included to ensure specificity. 21
Nox4 KO rat generation 22
Nox4 KO rats were generated at Sage Labs using the CompoZr Zinc Finger Nuclease 23 technology. The E14-15 domain (2.3-2.4 Kb) of the Nox4 gene was removed in a WKY 24 background rat. Zinc-Finger Nucleases (ZFNs) were coupled with a FOK1 25 endonuclease and designed to recognize and cleave the specific NOX4 sequence 1 producing sequence-specific double-strand breaks that are repaired by error-prone 2 non-homologous end joining (NHEJ) or high-fidelity homologous recombination (HR). 3
The Nox4 KO rat was generated by introducing variable genomic deletions that result 4 in a frameshift within the open reading frame. The frameshifts often result in the 5 introduction of a premature stop codon. When the premature stop codon occurs before 6 the last exon, the transcript is likely degraded via nonsense mediated decay pathway 7 and little or no protein is expressed. Resulting animals were screened for mutations 8 and complete genomic sequencing was performed. 9
Nox4 KO rat genotyping 10 DNA isolation and PCR from rat tail cuts was performed using the Quanta 11
Bioscoences AccuStart II Rat/Mouse genotyping kit (VWR cat no. 95135-500) 12 according to the instructions from the manufacturer with the following primers: forward 13 Int13 Cel1. 5'-TGTCTGCCAGAGCATTCACTA-3', reverse Int13 Cel1 5'-14 CAAATGGACTTCCAAATGGG-3' and reverse Int15 Cel1 5'-15 CTTCTGCAGTCTACCCTGGC-3'. A 2% Agarose gel was used, running for 45-50 16 minutes. Expected PCR products are 383bp for WT and 300bp for KO. 17
Verification of NOX4 deficiency in Nox4 KO rats 18
Brain, kidney and lung tissue were collected from WT and Nox4 KO rats. mRNA 19 isolation and cDNA preparation were prepared as previously described. mRNA levels 20 of Nox1, Nox2 and Nox4 in brain, kidney and lung were quantified by using the 21 fluorescent Taqman ® technology. We used TaqMan ® gene expression arrays 22 (TaqMan ® Universal PCR Master Mix, ThermoFisher Scientific, The Netherlands) 23 specific for rat Nox1 (Rn00586652_m1, ThermoFisher Scientific, The Netherlands), 24
Nox2 (Rn00576710_m1, ThermoFisher Scientific, The Netherlands) and Nox4 25 (Rn01506793_m1, ThermoFisher Scientific, The Netherlands). Water controls were 1 included to ensure specificity and the comparative ΔCt method was used for relative 2 quantification of gene expression. 3
Stroke surgery (tMCAO model) 4
The model has previously been established as described in (1) for mice and (6) rat 5 surgery. Animals were anesthetized with isoflurane (2-2.5% in oxygen). The animal 6 was placed on a heating-pad, and rectal temperature was maintained at 37.0°C using 7 a feedback-controlled infrared lamp. Focal cerebral ischemia was induced using an 8 intraluminal filament technique. Using a surgical microscope (Wild M5A, Wild 9
Heerbrugg, Gais, CH), a midline neck incision was made and the right common and 10 external carotid arteries were isolated and permanently ligated. A microvascular clip 11 was temporarily placed on the internal carotid artery. A silicon rubber-coated 6.0 nylon 12 monofilament (602312PK10, Doccol Corporation, Sharon, MA, USA) for mice and 4.0 13 nylon monofilament (40SP, Doccol Corporation, Sharon, MA, USA) for rats was 14 inserted through a small incision into the common carotid artery and advanced into 15 the internal carotid artery until a resistance is felt. The tip of the monofilament should 16 be located intracranially at the origin of the right middle cerebral artery and thereby 17 interrupting blood flow. The filament was held in place by a tourniquet suture that has 18 been prepared before to prevent dislocation during the ischemia period and the wound 19 was closed. Reperfusion was initiated 1 hour after occlusion by monofilament removal 20 in mice and 1.5h for rat experiments. After the surgery, wounds were carefully sutured 21 and animals were allowed to recover from surgery in a temperature-controlled 22 cupboard. Animals were excluded from the stroke analysis, if animals died before the 23 predefined experimental end point, if an intracerebral hemorrhage occurred, if the 24 animal lost more than 20% of body weight or if the animal scored 0 on the Bederson 1 score (SI Appendix, Table S3 ). 2 Treatment with NOX inhibitor: GKT136901 3 GKT136901 was dissolved in a mixture of DMSO/water in a ratio of 1/99. GKT136901 4 (10 mg/kg) or vehicle (DMSO/water in a ratio of 1/99) were injected i.p. 1 h after 5 removal of the filament, i.e. 2 h after induction of tMCAO. 6
Brain infarct volume measurements 7
The ischemic lesion was measured 24 hours after MCAO using TTC staining (6). The 8 brain was cut in three (mice) or five (rats) 2mm thick coronal sections using a 9 mouse/rat brain slice matrix (Harvard Apparatus, Holliston, MA, USA). The slices were 10 soaked for 10 min in a freshly-prepared solution of 2% 2,3,5-triphenyltetrazolium 11 hydrochloride (TTC, Sigma-Aldrich Chemie GmbH, Munich, Germany. Total indirect 12 
Neurological behaviour 19
The mice were assessed for neurological behaviour just before sacrifice to determine 20 the final functional status. Neurological deficits were measured in a blinded manner 21 on a 0 to 5 scale using the Bederson Score (8) with the following definitions for mice 22 and rats: 23
Mice: Score 0, no apparent neurological deficits; 1, body torsion and forelimb flexion; 1 2, right side weakness and thus decreased resistance to lateral push; 3, unidirectional 2 circling behaviour; 4, longitudinal spinning; 5, no movement. 
Motor function 7
Prior to sacrifice, the mice and rats were also scored for neurological motor deficits 8 according to the Grip Test (9). Each mouse was given a discrete value from 0 to 5. 9
This score is used to evaluate motor function and coordination. The apparatus is a 10 metal rod (0.22 cm diameter, 50cm length) between two vertical supports at a height 11 of 40 cm over a flat surface. The animal is placed mid-way on this rod and is rated 12 according to the following system: Score 0, falls off; 1, hangs on to string by one or 13 both fore paws; 2, as for 1, and attempts to climb on to string; 3, hangs on to string by 14 one or both fore paws plus one or both hind paws; 4, hangs on to string by fore and 15 hind paws plus tail wrapped around string; 5, escape (towards the supports). 16
Protein Extraction and Western Blot Analysis 17
Western blot analysis was performed according to standard procedures (10). The 18 following primary antibodies were used: polyclonal antibody (pAb) anti-occludin 19 (ab31721, Abcam), and mAb anti-b-actin (A5441, Sigma-Aldrich). 20
Blood-brain barrier function 21
To determine the permeability of the cerebral vasculature and brain edema, 2% Evans 22 blue tracer (Sigma Aldrich, Germany) diluted in 0.9% NaCl was injected intravenously 23 at reperfusion. Measurement of Evans Blue extravasation was performed as 24 described in (1) . 25
Oxidative stress: DHE staining 1
The presence of ROS was determined using dihydroethidium (Sigma, stock solution 2 2mM) staining in coronal brain sections taken from identical regions (-0.5mm from 3 bregma) of the different animal groups. Briefly, frozen sections were incubated in 2μM 4 DHE for 30 minutes at 37°C, washed three times with PBS and incubated with Hoechst 5 (Hoechst 33342, Sigma-Aldrich) 2ng/ml for 10 min. All sections were analyzed and 6 acquired with a Nikon Eclipse 50i microscope equipped with the DS-U3 DS camera 7 control unit. The relative pixel intensity was measured in identical regions with NIS-8
Elements software (Nikon, Tokyo, Japan). Digital images were processed using 9
Adobe Photoshop (Adobe Systems, San Jose, CA). 10
Cell death measurement 11
Apoptotic neurons were visualized by TUNEL analysis on cryopreserved brain 12 sections as described in (11). The TUNEL in situ death detection kit TMR red (Roche, 13 Switzerland) was used according to the manufacturer's instructions. Afterwards, slices 14 were washed and subsequently covered with AquaTec (Merck, Darmstadt, Germany). 15
All sections were analyzed with a Nikon Eclipse 50i microscope equipped with the DS-16 U3 DS camera control unit and NIS-Elements software (Nikon, Tokyo, Japan). Digital 17 images were processed using Adobe Photoshop (Adobe Systems, San Jose, CA). 
Murine model of hindlimb ischemia 3
The right femoral artery was permanently ligated. The mouse was placed on a heating 4 pad (UNO temperature control unit, UNO Roestvaststaal BV) and body temperature 5 was monitored using a rectal probe and maintained at 37°C using a feedback-6 controlled infrared lamp. A suture (5-0 silk) was placed around the femoral artery in 7 between the branching of the a. epigastrica and the a. poplitea. These last two arteries 8
were also ligated to prevent collateral flow and backflow respectively. The wound was 9 then closed with a 4-0 polysorb suture. Animals were sacrificed 4 weeks after femoral 10 artery ligation. 11
In the study, 23 WT and 17 KO animals were used. Two of the 25 WT animals died 12 due to bleeding complications during the surgery. A Doppler measurement after the 13 surgery was performed to exclude animals with no cessation of blood flow (SI 14 Appendix, Table S3 ). This post-doppler measurement confirmed correct ligation of 15 the artery and thus cessation of the blood flow in all of the animals. 16
Doppler measurements 17
Doppler measurements were done before and directly after surgery, at day 3, day 14 18 and day 28 after surgery. Mice were anesthetized and placed on the heating plate of 19 the Moor Laser-Doppler (Moor LDI2™, Moor Instruments LtD Millwey Axminster Devon 20 UK). The mouse was allowed to heat up for 10 minutes before starting the scan. Three 21 consecutive scans were made for each mouse. An area of interest was drawn around 22 the paws and the mean color pixel value was calculated per paw and expressed as 23 ratio of ligated over non-ligated leg. 24
25

Capillary density 1
Muscle samples were dissected and formalin-fixed. Paraffin embedded sections (4μm) 2 of the musculus adductor and musculus gastrocnemius were used for CD31 staining. 3 Antigen retrieval was achieved by heat induced epitope retrieval using 0.01 M Citrate 4 buffer (pH 6.0). Slides were incubated at 4°C overnight with the primary antibody, 5 monoclonal rat anti-mouse antibody to CD31 (PECAM-1) (Histonova-Dianova, Cat. no 6 DIA310) diluted 1:50. As secondary antibody, biotin labelled rabbit anti-rat antibody 7 (dakocytomotion Denmark no. E0468) was used diluted 1:200 (incubation for 30 8 minutes). Pictures were taken using a Leica camera connected to a Zeiss microscope. 9
Pictures were analysed using the Leica Qwin pro v3.5.1 software. For each animal, 10 three random pictures were taken per muscle sample and the amount of capillaries is 11 expressed as number per square mm. 12
Myocardial infarction and ischemia-reperfusion of the heart models 13
Mice were anaesthetized with isoflurane in air (Abbott forene Isoflurane, 4-5% for 14 induction, 2-3% for maintenance) and intubated per orally with a stainless-steel tube 15 connected to a respirator (rodent ventilator Microvent type 845, Hugo Sachs 16 Electronic, Germany), set at a stroke volume of 250μL and a rate of 210 strokes/min. 17
Body temperature was monitored using a rectal probe and maintained at 37.0°C using 18 a feedback-controlled infrared lamp and a heating plate. During surgery, an ECG was 19 recorded with IDEEQ software (IDEE, Maastricht University). Using a left thoracotomy, 20 the left descending coronary artery (LAD) was ligated with a 6-0 polyprolene suture 21 permanently for myocardial infarction (MI). For the transient ischemia of 45 minutes, 22 a small poly-ethylene tube was inserted under the ligature, compressing the coronary 23 artery, which was then removed after the ischemic period. During the ischemic period, 24 mice were kept under anesthesia. The chest was closed with 5-0 silk sutures (Ethicon). 25
The animals were weaned from the respirator and the endotracheal tube was 1 removed, once the mice breathed spontaneously. After surgery, mice were allowed to 2 recover in a thermoneutral temperature (28 °C). After 24 hours (short term transient 3 ischemia), an ultrasound was performed followed by terminal hemodynamic 4 characterisation (see below), then the heart was excised and used for infarct size 5 measurements (see below TTC stain). At the end of the long-term experiment (28 6 days), hearts were quickly excised and the atria were removed. The ventricles were 7 cut transversally at 3mm from the apex. The apical part was shock frozen for mRNA 8 extraction. The basal part was fixed in formalin and processed for paraffin embedding. 9
Animals included 10
Short term study: In total, 46 KO and 48 WT animals were included in the complete 11 study. For infarct size measurements, 19 WT and 18 KO animals were used. For one 12 KO animal no reperfusion was seen, one WT animal did not have a visible ischemia 13 and 3 WT animals died during surgery or before the endpoint of 24h. The remaining 14 17 WT and 16 KO animals were included in the infarct size analysis using the intention 15 to treat principle (SI Appendix, Table S3 ). For ultrasounds, data were excluded if one 16 of the repeated measurements was missing resulting in 39 WT and 36 KO animals. 17
The hemodynamic measurements were performed in 11WT and 16KO animals. could not be included in the infarct size analysis due to technical problems. The 25 remaining 15WT and 17KO mice were included according to intention to treat principle 1 (SI Appendix, Table S3 ). For the ultrasounds, data were excluded if one of the 2 repeated measurements was missing resulting in 21 WT and 23 KO 
In vivo echocardiography measurements were performed under light isoflurane 9 anaesthesia before the surgery and at day 1 (short term) or 14 and 28 (long term), 10 using the Vevo 2100 echocardiography system (Visualsonics, Toronto, Canada). Two-11 dimensional B-Mode echocardiograms were captured at a rate of 90-120 Hz from 12 parasternal long-axis views as well as from mid-papillary short axis-views of the left 13 ventricle. Data were obtained from at least 3 different images taken in end-diastole 14 and systole using the accompanying software from the Vevo 2100 echocardiography 15 system. From the long-axis echocardiograms, the ejection fraction (EF) was defined 16 as 100* (EDV-ESV)/EDV) (12, 13). 17
Evaluation of left ventricular contractility 18
Left ventricular contractility was measured at day 1 or 28 before sacrifice. Mice were 19 anaesthetized with urethane 2.5mg/kg intraperitoneally (Sigma). Body temperature 20 and respiration were controlled as described above. A high-fidelity pressure 21 transducer (Mikro-tip, 1.4F, SPR-671 Millar Instruments, Houston, TX, USA) was 22 inserted into the left ventricle via the right carotid artery. Ventricular pressure was 23 measured and sampled at a rate of 2kHz. After a baseline measurement, the heart 24 was stimulated by intravenous infusion of increasing doses of dobutamine (Sigma) via 25 a microinjection pump (Model 200 series, KdScientific, Boston, MA, USA) starting at 1 90μg/min and increasing by 90μg every two minutes to a maximum dose of 540μg/min. 2 Heart rate, maximal positive pressure and minimal positive pressure were calculated 3 for every infusion rate using IdeeQ software. 4
Evaluation of infarct size short term study 5
After reopening the chest, the left descending coronary artery was ligated again at the 6 same spot. Then, Evans Blue ink was injected via the inferior vena cava and allowed 7 to spread through the vascular system. Then, the hearts were quickly excised and 8 frozen. After freezing, the hearts were cut into 4-5 slices of 2mm and soaked in TTC 9 (2% in PBS) for 30 minutes. Pictures were taken with a Dinolite camera connected to 10 the microscope. Area at risk and infarct size were were analysed using the Leica Qwin 11 pro v3.5.1 software. Infarct sizes are expressed as percentage of total left ventricular 12
area. 13
Evaluation of infarct size long term study 14
Infarct sizes were calculated from paraffin-embedded left ventricular sections stained 15 with AZAN. Sections of 4μm were incubated in preheated AZAN I solution for 30 16 minutes at 37°C, followed by rinsing in demineralized water and incubation in 5% 17 phosphotungstic acid for 45 minutes. After rinsing in tap water, slides were finally 18 incubated in AZAN II solution (diluted 1:3 in demineralized water) for 10 minutes. 19
Pictures were taken using a Leica camera connected to a Zeiss microscope. Pictures 20 were analysed using the Leica Qwin pro v3.5.1 software. Infarct sizes are expressed 21 as percentage area of the total left ventricular tissue area. 22
Hippocampal brain slices 23
In vitro damage caused by oxygen-glucose deprivation/re-oxygenation and the 24 protection elicited by VAS2870 and GKT136901 was studied in acutely isolated rat 25 hippocampal slices. Brains from 2-3 months old adult male Sprague-Dawley rats (250-1 300 g) or Nox4 KO mice (2-3 months) were isolated as described previously (14). Rats 2 or mice were quickly decapitated and forebrains were rapidly removed from the skull 3 and placed into ice-cold Krebs bicarbonate dissection buffer (pH 7.4), containing (in 4 mM): NaCl 120, KCl 2, CaCl 2 0.5, NaHCO 3 26, MgSO 4 10, KH 2 PO 4 1.18, glucose 11 5 and sucrose 200. The chamber solutions were pre-bubbled with either 95% O 2 /5% 6 CO 2 or 95% N 2 /5% CO 2 gas mixtures, for at least 30 min before slice immersion, to 7 ensure O 2 saturation or removal. The hippocampi were quickly dissected and 300mm 8 thick slices were cut using a McIlwain Tissue Chopper. Then, the slices were 9 transferred to vials containing a sucrose-free dissection buffer, bubbled with 95% 10 O 2 /5% CO 2 in a water bath at 37°C for 45 min, to allow tissue recovery (equilibration 11 period). Oxygen and glucose deprivation was induced by incubating the slices for a 12 15 min period in a glucose-free Krebs solution (glucose was replaced by 2-13 deoxyglucose), equilibrated with a 95% N 2 /5% CO 2 gas mixture. Slices incubated for 14 15 min in a modified Krebs solution (in mM: NaCl 120, KCl 2, CaCl 2 2, NaHCO 3 26, 15
MgSO 4 1.19, KH 2 PO 4 1.18 and glucose 11), equilibrated with 95% O 2 /5% CO 2 served 16 as controls. After the OGD period, the slices were returned back to an oxygenated 17 normal Krebs solution containing glucose for 2h (re-oxygenation period), during which 18 VAS2870 (10 ) or GKT136901 (0.1 ) were added as treatments do the rat 19 studies. In case of Nox4 KO mice, no treatment was used. 20
Cell viability of hippocampal slices 21
Hippocampal cell viability was determined using the colorimetric MTT assay (14). 22
Hippocampal slices were collected immediately after the re-oxygenation period and 23
were incubated with MTT (0.5 mg/ml) in Krebs bicarbonate solution for 30 min at 37°C. 24
The tetrazolium ring of MTT can be cleaved by active dehydrogenases in viable cells, 25 producing a precipitated formazan derivative. This formazan derivative was solubilized 1 by adding 200 µl DMSO. The optical density was measured spectrophotometrically at 2 540 nm using a micro plate reader. Absorbance values obtained in control slices were 3 set to 100% viability and experimental variables were normalized with respect to this 4 value. 5
ROS determination in hippocampal brain slices 6
To measure cellular reactive oxygen species (ROS), we used the molecular probe 7 H 2 DCFDA (34). Immediately after chopper sectioning, 300μm thick hippocampal slices 8 were loaded with H 2 DCFDA (10 µl/ml) for 40 min in Krebs solution. Subsequently, the 9 slices were washed once with Krebs solution during 10 min and OGD/Re-Ox protocol 10 started. Fluorescence was measured in each slice using a fluorescence inverted 11 NIKON eclipse T2000-U microscope (Izasa, Madrid, Spain). Wavelengths of excitation 12 and emission of H 2 DCFDA were 485 and 520 respectively. Images were taken at CA1 13 at magnifications of 100x. Fluorescence analysis was performed using the Metamorph 14 programme version 7.0. Fluorescence under basal conditions was set to 1 and 15 experimental variables were normalized with respect to this value. 16
Human brain microvascular endothelial cells (HBMEC) culture subjected to 17
hypoxia 18 HBME cells (Cell systems, USA) between passage 3 and 9 were cultured to 19 approximately 90% confluence using specialized cell medium (EGM-2 MV BulletKit, 20
Lonza, The Netherlands) enriched with 5% fetal bovine serum FBS before starting the 21 hypoxia period. For cell studies, HBMECs were seeded at specific density (6 10 * 22 cells/ml) in 12 wells-plates and incubated during 24h at 37°C. Later, cell medium was 23 replaced for non-FBS containing medium (2ml/well) following by 6h of hypoxia (94,8% 24 N 2 , 0.2% O 2 and 5% CO 2 ) at 37°C using hypoxia workstations (Ruskin Invivo2 400 25 station, The Netherlands). The hypoxia period was followed by 24h of reperfusion in 1 presence or absence of 1 µM GKT136901 (Genkyotech, Switzerland) as treatment. 2
Control cells were exposed to normoxia (75% N 2 , 20% O 2 and 5% CO 2 ) and enriched 3 medium during the hypoxia period. All flasks and well plates were pre-treated with 4 fibronectin (Sigma-Aldrich, The Netherlands) solution (1:100 in PBS). 5
Assessment of cell viability in HBMEC 6
After 24h reperfusion, cell viability was assessed using the colorimetric MTT assay 7 (14). MTT solution (5 mg/ml) was added to each well (100 µl/ml) and incubated for 2h 8 at 37°C. The formazan salt formed was solubilized by adding 350 µl DMSO. The 9 optical density was measured spectrophotometrically at 540 nm using a micro plate 10 reader. Absorbance values obtained in control cells were set to 100% viability. 11
Cell permeability in HBMEC 12
For the passive diffusion assay 2 x 10 4 HBMEC were grown to confluence on 13 was removed from the upper and lower chamber of the Transwell system. The lower 21 chamber was filled with ACSF solution (ACSF; 120 mM NaCl, 2.5 mM KCl, 1.25 mM 22 NaH2PO4, 22 mM NaHCO3, 2 mM MgSO4, 2 mM CaCl2, and 20 mM glucose), the 23 upper chambers with 25µg/ml tracer, diluted in ACSF solution. After 5 min incubation 24 at 37°C. The amount of diffused tracer in the lower chamber was measured with Tecan 1 infinite M200PRO (TECAN, Männedorf, Switzerland). 2 Evans Blue extravasation: Cell permeability was assessed using the Evans Blue dye 3 (Sigma-Aldrich, The Netherlands). To initiate the diffusion experiments, the medium 4 was removed and cells were washed once with assay buffer. The same buffer (1.5 ml) 5 was added to the abluminal side of the insert. Permeability buffer (0.5 ml) containing 6 4% bovine serum albumin (Sigma-Aldrich, The Netherlands) and 0.67 mg/ml Evans 7 blue dye was loaded on the luminal side of the insert followed by 15 min incubation at 8 37°C. The concentration of Evans Blue in the abluminal chamber was measured by 9 determining the absorbance of 150 µl buffer at 630 nm using a microplate reader. were generated in an analogous way using SMMHC-Cre+ mice and CaMKII-Cre+ 8 mice respectively. Deletion of Nox4 in SMC and neurons was Tamoxifen-inducible. 9
sWT and nWT mice were also injected with Tamoxifen for proper comparison. with nWT (** P < 0.01, n = 8) while no effect was shown in eKO mice (n = 8). 
